 | • レポートコード：B-GIR09D1717 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、高度免疫グロブリンの世界市場について調べ、まとめました。種類別セグメントは、B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他等、用途別セグメントは、政府機関、民間部門、その他等に区分しました。高度免疫グロブリンの世界市場概観、メーカー動向、メーカー別高度免疫グロブリンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・高度免疫グロブリンの市場概観 ・高度免疫グロブリンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・高度免疫グロブリンの企業別販売動向、市場シェア、市場集中度、競争動向 ・高度免疫グロブリンの世界市場規模 ・高度免疫グロブリンの北米市場分析（アメリカ、カナダ、メキシコ等） ・高度免疫グロブリンのアメリカ市場規模推移 ・高度免疫グロブリンのカナダ市場規模推移 ・高度免疫グロブリンのメキシコ市場規模推移 ・高度免疫グロブリンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・高度免疫グロブリンのドイツ市場規模推移 ・高度免疫グロブリンのイギリス市場規模推移 ・高度免疫グロブリンのロシア市場規模推移 ・高度免疫グロブリンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・高度免疫グロブリンの日本市場規模推移 ・高度免疫グロブリンの中国市場規模推移 ・高度免疫グロブリンの韓国市場規模推移 ・高度免疫グロブリンのインド市場規模推移 ・高度免疫グロブリンの東南アジア市場規模推移 ・高度免疫グロブリンの南米市場分析（ブラジル、アルゼンチン等） ・高度免疫グロブリンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・高度免疫グロブリンの種類別分析/販売量、売上、市場シェア（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他） ・高度免疫グロブリンの用途別分析/市場規模（政府機関、民間部門、その他） ・高度免疫グロブリンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・高度免疫グロブリンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. This is in contrast to vaccines that provide “active” immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant “passive” short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Scope of the Report:
Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The worldwide market for Hyperimmune Globulins is expected to grow at a CAGR of roughly 11.6% over the next five years, will reach 140 million US$ in 2024, from 82 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Hyperimmune Globulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Others
Market Segment by Applications, can be divided into
Government Institutions
Private Sector
Other
There are 15 Chapters to deeply display the global Hyperimmune Globulins market.
Chapter 1, to describe Hyperimmune Globulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hyperimmune Globulins, with sales, revenue, and price of Hyperimmune Globulins, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyperimmune Globulins, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
1.1 Hyperimmune Globulins Introduction
1.2 Market Analysis by Type
1.2.1 Hepatitis B Immunoglobulins
1.2.2 Rabies Immunoglobulins
1.2.3 Tetanus Immunoglobulins
1.2.4 Rho(D) Immunoglobulins
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Government Institutions
1.3.2 Private Sector
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Nigeria Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Hyperimmune Globulins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Hyperimmune Globulins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Biotest
2.3.1 Business Overview
2.3.2 Hyperimmune Globulins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Kedrion
2.4.1 Business Overview
2.4.2 Hyperimmune Globulins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CBPO
2.5.1 Business Overview
2.5.2 Hyperimmune Globulins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Emergent (Cangene)
2.6.1 Business Overview
2.6.2 Hyperimmune Globulins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Kamada
2.7.1 Business Overview
2.7.2 Hyperimmune Globulins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 CNBG
2.8.1 Business Overview
2.8.2 Hyperimmune Globulins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hualan Bio
2.9.1 Business Overview
2.9.2 Hyperimmune Globulins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Shanghai RAAS
2.10.1 Business Overview
2.10.2 Hyperimmune Globulins Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sichuan Yuanda Shuyang
2.11.1 Business Overview
2.11.2 Hyperimmune Globulins Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 ADMA Biologics
2.12.1 Business Overview
2.12.2 Hyperimmune Globulins Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hyperimmune Globulins Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Hyperimmune Globulins Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Hyperimmune Globulins Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Hyperimmune Globulins Manufacturer Market Share in 2018
3.3.2 Top 6 Hyperimmune Globulins Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Hyperimmune Globulins Market Analysis by Regions
4.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Regions
4.1.1 Global Hyperimmune Globulins Sales and Market Share by Regions (2014-2019)
4.1.2 Global Hyperimmune Globulins Revenue and Market Share by Regions (2014-2019)
4.2 North America Hyperimmune Globulins Sales and Growth Rate (2014-2019)
4.3 Europe Hyperimmune Globulins Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2014-2019)
4.5 South America Hyperimmune Globulins Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)
5 North America Hyperimmune Globulins by Countries
5.1 North America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
5.1.1 North America Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
5.1.2 North America Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
5.2 United States Hyperimmune Globulins Sales and Growth Rate (2014-2019)
5.3 Canada Hyperimmune Globulins Sales and Growth Rate (2014-2019)
5.4 Mexico Hyperimmune Globulins Sales and Growth Rate (2014-2019)
6 Europe Hyperimmune Globulins by Countries
6.1 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
6.1.2 Europe Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
6.2 Germany Hyperimmune Globulins Sales and Growth Rate (2014-2019)
6.3 UK Hyperimmune Globulins Sales and Growth Rate (2014-2019)
6.4 France Hyperimmune Globulins Sales and Growth Rate (2014-2019)
6.5 Russia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
6.6 Italy Hyperimmune Globulins Sales and Growth Rate (2014-2019)
7 Asia-Pacific Hyperimmune Globulins by Countries
7.1 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
7.1.2 Asia-Pacific Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
7.2 China Hyperimmune Globulins Sales and Growth Rate (2014-2019)
7.3 Japan Hyperimmune Globulins Sales and Growth Rate (2014-2019)
7.4 Korea Hyperimmune Globulins Sales and Growth Rate (2014-2019)
7.5 India Hyperimmune Globulins Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
8 South America Hyperimmune Globulins by Countries
8.1 South America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
8.1.1 South America Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
8.1.2 South America Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
8.2 Brazil Hyperimmune Globulins Sales and Growth Rate (2014-2019)
8.3 Argentina Hyperimmune Globulins Sales and Growth Rate (2014-2019)
8.4 Colombia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
9 Middle East and Africa Hyperimmune Globulins by Countries
9.1 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
9.1.2 Middle East and Africa Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
9.2 Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
9.3 UAE Hyperimmune Globulins Sales and Growth Rate (2014-2019)
9.4 Egypt Hyperimmune Globulins Sales and Growth Rate (2014-2019)
9.5 Nigeria Hyperimmune Globulins Sales and Growth Rate (2014-2019)
9.6 South Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)
10 Global Hyperimmune Globulins Market Segment by Type
10.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Hyperimmune Globulins Sales and Market Share by Type (2014-2019)
10.1.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2014-2019)
10.2 Hepatitis B Immunoglobulins Sales Growth and Price
10.2.1 Global Hepatitis B Immunoglobulins Sales Growth (2014-2019)
10.2.2 Global Hepatitis B Immunoglobulins Price (2014-2019)
10.3 Rabies Immunoglobulins Sales Growth and Price
10.3.1 Global Rabies Immunoglobulins Sales Growth (2014-2019)
10.3.2 Global Rabies Immunoglobulins Price (2014-2019)
10.4 Tetanus Immunoglobulins Sales Growth and Price
10.4.1 Global Tetanus Immunoglobulins Sales Growth (2014-2019)
10.4.2 Global Tetanus Immunoglobulins Price (2014-2019)
10.5 Rho(D) Immunoglobulins Sales Growth and Price
10.5.1 Global Rho(D) Immunoglobulins Sales Growth (2014-2019)
10.5.2 Global Rho(D) Immunoglobulins Price (2014-2019)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2014-2019)
10.6.2 Global Others Price (2014-2019)
11 Global Hyperimmune Globulins Market Segment by Application
11.1 Global Hyperimmune Globulins Sales Market Share by Application (2014-2019)
11.2 Government Institutions Sales Growth (2014-2019)
11.3 Private Sector Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Hyperimmune Globulins Market Forecast (2019-2024)
12.1 Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2019-2024)
12.2 Hyperimmune Globulins Market Forecast by Regions (2019-2024)
12.2.1 North America Hyperimmune Globulins Market Forecast (2019-2024)
12.2.2 Europe Hyperimmune Globulins Market Forecast (2019-2024)
12.2.3 Asia-Pacific Hyperimmune Globulins Market Forecast (2019-2024)
12.2.4 South America Hyperimmune Globulins Market Forecast (2019-2024)
12.2.5 Middle East and Africa Hyperimmune Globulins Market Forecast (2019-2024)
12.3 Hyperimmune Globulins Market Forecast by Type (2019-2024)
12.3.1 Global Hyperimmune Globulins Sales Forecast by Type (2019-2024)
12.3.2 Global Hyperimmune Globulins Market Share Forecast by Type (2019-2024)
12.4 Hyperimmune Globulins Market Forecast by Application (2019-2024)
12.4.1 Global Hyperimmune Globulins Sales Forecast by Application (2019-2024)
12.4.2 Global Hyperimmune Globulins Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Hyperimmune Globulins Picture
Table Product Specifications of Hyperimmune Globulins
Figure Global Sales Market Share of Hyperimmune Globulins by Types in 2018
Table Hyperimmune Globulins Types for Major Manufacturers
Figure Hepatitis B Immunoglobulins Picture
Figure Rabies Immunoglobulins Picture
Figure Tetanus Immunoglobulins Picture
Figure Rho(D) Immunoglobulins Picture
Figure Others Picture
Figure Hyperimmune Globulins Sales Market Share by Applications in 2018
Figure Government Institutions Picture
Figure Private Sector Picture
Figure Other Picture
Figure United States Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure France Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure UK Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure China Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure India Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Hyperimmune Globulins Revenue (Value) and Growth Rate (2014-2024)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Hyperimmune Globulins Type and Applications
Table CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Hyperimmune Globulins Type and Applications
Table Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Hyperimmune Globulins Type and Applications
Table Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Hyperimmune Globulins Type and Applications
Table Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Hyperimmune Globulins Type and Applications
Table CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
Table Emergent (Cangene) Hyperimmune Globulins Type and Applications
Table Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Kamada Basic Information, Manufacturing Base and Competitors
Table Kamada Hyperimmune Globulins Type and Applications
Table Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG Hyperimmune Globulins Type and Applications
Table CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Hyperimmune Globulins Type and Applications
Table Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table Shanghai RAAS Hyperimmune Globulins Type and Applications
Table Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table Sichuan Yuanda Shuyang Hyperimmune Globulins Type and Applications
Table Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table ADMA Biologics Hyperimmune Globulins Type and Applications
Table ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hyperimmune Globulins Sales by Manufacturer (2017-2018)
Figure Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Figure Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2018
Table Global Hyperimmune Globulins Revenue by Manufacturer (2017-2018)
Figure Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Figure Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2018
Figure Top 3 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2018
Figure Global Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Global Hyperimmune Globulins Revenue and Growth Rate (2014-2019)
Table Global Hyperimmune Globulins Sales by Regions (2014-2019)
Table Global Hyperimmune Globulins Sales Market Share by Regions (2014-2019)
Table Global Hyperimmune Globulins Revenue by Regions (2014-2019)
Figure Global Hyperimmune Globulins Revenue Market Share by Regions in 2014
Figure Global Hyperimmune Globulins Revenue Market Share by Regions in 2018
Figure North America Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Europe Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure South America Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure North America Hyperimmune Globulins Revenue and Growth Rate (2014-2019)
Table North America Hyperimmune Globulins Sales by Countries (2014-2019)
Table North America Hyperimmune Globulins Sales Market Share by Countries (2014-2019)
Figure North America Hyperimmune Globulins Sales Market Share by Countries in 2014
Figure North America Hyperimmune Globulins Sales Market Share by Countries in 2018
Table North America Hyperimmune Globulins Revenue by Countries (2014-2019)
Table North America Hyperimmune Globulins Revenue Market Share by Countries (2014-2019)
Figure North America Hyperimmune Globulins Revenue Market Share by Countries in 2014
Figure North America Hyperimmune Globulins Revenue Market Share by Countries in 2018
Figure United States Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Canada Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Mexico Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Europe Hyperimmune Globulins Revenue and Growth Rate (2014-2019)
Table Europe Hyperimmune Globulins Sales by Countries (2014-2019)
Table Europe Hyperimmune Globulins Sales Market Share by Countries (2014-2019)
Table Europe Hyperimmune Globulins Revenue by Countries (2014-2019)
Figure Europe Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Europe Hyperimmune Globulins Revenue Market Share by Countries in 2018
Figure Germany Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure UK Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure France Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Russia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Italy Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Hyperimmune Globulins Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hyperimmune Globulins Sales by Countries (2014-2019)
Table Asia-Pacific Hyperimmune Globulins Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Hyperimmune Globulins Sales Market Share by Countries 2018
Table Asia-Pacific Hyperimmune Globulins Revenue by Countries (2014-2019)
Figure Asia-Pacific Hyperimmune Globulins Revenue Market Share by Countries 2018
Figure China Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Japan Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Korea Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure India Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure South America Hyperimmune Globulins Revenue and Growth Rate (2014-2019)
Table South America Hyperimmune Globulins Sales by Countries (2014-2019)
Table South America Hyperimmune Globulins Sales Market Share by Countries (2014-2019)
Figure South America Hyperimmune Globulins Sales Market Share by Countries in 2018
Table South America Hyperimmune Globulins Revenue by Countries (2014-2019)
Table South America Hyperimmune Globulins Revenue Market Share by Countries (2014-2019)
Figure South America Hyperimmune Globulins Revenue Market Share by Countries in 2018
Figure Brazil Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Argentina Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Colombia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Hyperimmune Globulins Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hyperimmune Globulins Sales by Countries (2014-2019)
Table Middle East and Africa Hyperimmune Globulins Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Hyperimmune Globulins Sales Market Share by Countries in 2018
Table Middle East and Africa Hyperimmune Globulins Revenue by Countries (2014-2019)
Table Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries in 2014
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure UAE Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Egypt Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure Nigeria Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Figure South Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)
Table Global Hyperimmune Globulins Sales by Type (2014-2019)
Table Global Hyperimmune Globulins Sales Share by Type (2014-2019)
Table Global Hyperimmune Globulins Revenue by Type (2014-2019)
Table Global Hyperimmune Globulins Revenue Share by Type (2014-2019)
Figure Global Hepatitis B Immunoglobulins Sales Growth (2014-2019)
Figure Global Hepatitis B Immunoglobulins Price (2014-2019)
Figure Global Rabies Immunoglobulins Sales Growth (2014-2019)
Figure Global Rabies Immunoglobulins Price (2014-2019)
Figure Global Tetanus Immunoglobulins Sales Growth (2014-2019)
Figure Global Tetanus Immunoglobulins Price (2014-2019)
Figure Global Rho(D) Immunoglobulins Sales Growth (2014-2019)
Figure Global Rho(D) Immunoglobulins Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Hyperimmune Globulins Sales by Application (2014-2019)
Table Global Hyperimmune Globulins Sales Share by Application (2014-2019)
Figure Global Private Sector Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2019-2024)
Table Global Hyperimmune Globulins Sales Forecast by Regions (2019-2024)
Table Global Hyperimmune Globulins Market Share Forecast by Regions (2019-2024)
Figure North America Sales Hyperimmune Globulins Market Forecast (2019-2024)
Figure Europe Sales Hyperimmune Globulins Market Forecast (2019-2024)
Figure Asia-Pacific Sales Hyperimmune Globulins Market Forecast (2019-2024)
Figure South America Sales Hyperimmune Globulins Market Forecast (2019-2024)
Figure Middle East and Africa Sales Hyperimmune Globulins Market Forecast (2019-2024)
Table Global Hyperimmune Globulins Sales Forecast by Type (2019-2024)
Table Global Hyperimmune Globulins Market Share Forecast by Type (2019-2024)
Table Global Hyperimmune Globulins Sales Forecast by Application (2019-2024)
Table Global Hyperimmune Globulins Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の皮膚線維症薬市場予測（～2024年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of e…- 世界の皮膚線維症治療市場予測（～2024年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of e…
- 世界の小売セクターにおけるブロックチェーン市場予測（～2024年） A blockchain, originally block chain, is a growing list of records, called blocks, which are linked using cryptography. Each block contains a cryptographic hash of the previous block, a timestamp, and transaction data (generally represented as a Merkle tree). Scope of the Report: The global Blockcha…
- 世界の教育部門におけるクラウドコンピューティング市場予測（～2024年） Cloud computing is the on demand availability of computer system resources, especially data storage and computing power, without direct active management by the user. The term is generally used to describe data centers available to many users over the Internet. Large clouds, predominant today, often…
- 世界のプライベートLTE市場予測（～2024年） Most LTE networks are considered public, serving the general public or enterprise subscribers. An LTE network is considered to be private when its main purpose is to connect people/things belonging to an enterprise (normally in an enterprise campus), and where data needs to be kept totally secure by…